Prediction of the Risk of Biochemical Relapse After Radical Prostatectomy for Prostate Cancer Using Radomics on Pre-therapeutic MRI
CompletedOBSERVATIONAL
Enrollment
195
Participants
Timeline
Start Date
June 26, 2018
Primary Completion Date
August 28, 2018
Study Completion Date
August 28, 2018
Conditions
Prostatic Adenocarcinoma
Trial Locations (2)
29000
Centre Hospitalier de Cornouaille, Quimper
29609
CHRU de Brest, Brest
All Listed Sponsors
lead
University Hospital, Brest
OTHER
NCT04063800 - Prediction of the Risk of Biochemical Relapse After Radical Prostatectomy for Prostate Cancer Using Radomics on Pre-therapeutic MRI | Biotech Hunter | Biotech Hunter